MRNA
Companies
NASDAQ
Moderna Inc.
Health Care
$25.91
-$15.90 (-38.24%)
Price Chart
Overview
About MRNA
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Market Cap
$57.9B
Volume
316.5M
Avg. Volume
256.4M
P/E Ratio
-2.8574715
Dividend Yield
0.00%
Employees
5.3K
Company Information
Latest News for MRNA
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
June 2, 2025
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say
June 10, 2025
HHS cancels Moderna bird flu deal
May 29, 2025
What Sparked Moderna Stock Crash?
June 10, 2025
Moderna (MRNA) Advances While Market Declines: Some Information for Investors
June 20, 2025
Risk & Correlation Analysis
Market Correlation
0.83
Moderate Correlation
Volatility
High (0.70)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MRNA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$57.9B
Volume316.5M
P/E Ratio-2.86
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 1, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025